MABQUEST THERAPEUTICS

Live / Registered — Registered (as of 19 May 2026)

What this means for you

Registered since 19 May 2026. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
79435367
Registration number
8258456
Mark type
Design + words
Filed
29 Jul 2025
Published for opposition
31 Mar 2026
Registered
19 May 2026
Attorney of record
Andrea L. Hintz

Goods and services

  • Class 001 — Chemicals: Chemical, biochemical, biological and biotechnological preparations for use in industry and science other than for medical or veterinary use; chemical, biological and biotechnological preparations, in particular polypeptides and proteins for development or manufacture of reagents for use in industry and science; biological preparations, in particular polypeptides or proteins for use in laboratories and for non-medical diagnosis and analysis in industry and science; chemical and biochemical substances being additives for use in the manufacture of pharmaceuticals; chemical and biochemical substances for use in the manufacture of pharmaceuticals for treating cancer, autoimmune diseases, inflammatory disorders, and diseases in the fields of oncology and immunology; stem cells for research purposes; stem cells for scientific use; cultures of microorganisms other than for medical and veterinary use; cell culture media for scientific and research purposes
  • Class 005 — Pharmaceuticals: Pharmaceutical products for treatment of cancer, autoimmune diseases, inflammatory disorders, and diseases in the fields of oncology and immunology; medicinal preparations for disease treatment, namely, for preventing or treating cancer, autoimmune diseases, inflammatory disorders, and diseases in the fields of oncology and immunology; preparations for medical treatments, in particular preparations based on polypeptides and proteins for treatment of cancer, autoimmune diseases, inflammatory disorders, and diseases in the fields of oncology and immunology; protein complexes for diagnosing cancer, autoimmune diseases, inflammatory disorders, and diseases in the fields of oncology and immunology; synthetic peptides for pharmaceutical use, namely, for treatment of cancer, autoimmune diseases, inflammatory disorders, and diseases in the fields of oncology and immunology; diagnostic agents, preparations and substances for medical purposes; diagnostic substances for medical use; medicinal preparations and substances for preventing and treating cancer, autoimmune diseases, inflammatory disorders, and diseases in the fields of oncology and immunology; pharmaceutical preparations and substances for preventing and treating cancer, autoimmune diseases, inflammatory disorders, and diseases in the fields of oncology and immunology; agents and medicines for therapeutic use, namely, for the treatment of cancer, autoimmune diseases, inflammatory disorders, and diseases in the fields of oncology and immunology; cells for medical use; chemical, biochemical and biological preparations being biological, biochemical, and immunological pharmaceutical preparations for medical use
  • Class 042 — Scientific and technological services: Analysis and research in laboratories being research laboratory analysis services in the field of chemistry, biochemistry, and molecular biology; scientific research and analysis in the field of chemistry, biochemistry, molecular biology, and immunology; cell culture for scientific research purposes, for others; design and development of medical technologies; research and development in the field of biotechnology; research and development in the field of microorganisms and cells; research and development in the field of diagnostic preparations; pharmaceutical research and development; biochemical research and development; scientific and technological research, particularly in the biochemical, diagnostic or pharmaceutical fields; research and development for the pharmaceutical industry; research and development services in the field of proteins, microorganisms and cells; research and development services in the field of immunology; services of a chemical, biochemical and biological research laboratory; research services, namely, analyses in the field of molecular biology

Owner

Prosecution history

  • 19 Aug 2026 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
  • 19 May 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
  • 19 May 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
  • 19 May 2026 — REGISTERED-PRINCIPAL REGISTER
  • 31 Mar 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 31 Mar 2026 — PUBLISHED FOR OPPOSITION
  • 25 Mar 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 10 Mar 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 09 Mar 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
  • 09 Mar 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
  • 09 Mar 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
  • 12 Feb 2026 — REFUSAL PROCESSED BY IB
  • 24 Jan 2026 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
  • 24 Jan 2026 — REFUSAL PROCESSED BY MPU
  • 15 Dec 2025 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

View this trademark record on Marksy